⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL4263347 | 0.40 | — | — | |
| SCHEMBL6231 | 0.40 | — | — | |
| SCHEMBL8871827 | 0.40 | — | — | |
| SCHEMBL2016934 | 0.38 | — | — | |
| SCHEMBL4293665 | 0.36 | — | — | |
| Charcoal, Activated SCHEMBL10390519 | 0.36 | — | — | |
| SCHEMBL5557185 | 0.36 | — | — | |
| SCHEMBL7205518 | 0.36 | — | — | |
| Hydrogen Sulfide SCHEMBL8201731 | 0.36 | — | — | |
| Hydrogen Sulfide SCHEMBL7099124 | 0.36 | ALDH1A1 (0.80) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220033406-A1 | CYCLOPENTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS | Janssen Pharmaceuticals, Inc. | 2022-02-03 | — | — | US | disclosed |
| EP-3894395-A2 | CYCLOPENTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS | Janssen BioPharma, Inc. (US) | 2021-10-20 | — | — | EP | disclosed |
| WO-2020121123-A2 | CYCLOPENTYL NUCLEOSIDE ANALOGS AS ANTI-VIRALS | Janssen Biopharma, Inc. (US) | 2020-06-18 | — | — | WO | disclosed |
| EP-2221311-B1 | Novel nucleic acid base pair | TAGCYX BIOTECHNOLOGIES (JP) | 2013-08-21 | — | — | EP | disclosed |
| EP-1114827-B1 | NOVEL NUCLEIC ACID BASE PAIR | JAPAN SCIENCE & TECH AGENCY (JP) | 2010-11-17 | — | — | EP | disclosed |
| EP-2223931-A1 | Novel nucleic acid base pair | Japan Science and Technology Agency (JP) | 2010-09-01 | — | — | EP | disclosed |
| EP-2221311-A1 | Novel nucleic acid base pair | Japan Science and Technology Agency (JP) | 2010-08-25 | — | — | EP | disclosed |
| US-7667031-B2 | Nucleic acid base pair | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-02-23 | — | — | US | disclosed |
| US-20090286247-A1 | Novel nucleic acid base pair | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-11-19 | — | — | US | disclosed |
| US-7101992-B1 | Nucleic acid base pair | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2006-09-05 | — | — | US | disclosed |
| US-20020025936-A1 | Motilide compounds | PFIZER INC. | 2002-02-28 | — | — | US | disclosed |
| WO-2001073095-A2 | PREPARATION OF DEOXYNUCLEOSIDES | ISIS PHARMACEUTICALS, INC. (US) | 2001-10-04 | — | — | WO | disclosed |
| EP-1114827-A1 | NOVEL NUCLEIC ACID BASE PAIR | Japan Science and Technology Corporation (JP) | 2001-07-11 | — | — | EP | disclosed |
| EP-0507188-A1 | Substituted 2',3'-dideoxy-5-trifluoromethyluridines, method of their preparation and their use in medicaments | BAYER AG (DE) | 1992-10-07 | — | — | EP | disclosed |
| US-5011827-A | Elaiophyline derivatives, compositions containing them and the use thereof as anthelmintic agents | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-04-30 | — | — | US | disclosed |
| EP-0315003-A2 | Elaiophylin derivatives, method for their preparation, product containing them and its use | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-05-10 | — | — | EP | disclosed |
| CN-86106534-A | Carbocyclic purine nucleosides, its preparation and purposes | — | 1987-05-27 | — | — | CN | disclosed |
| EP-0219838-A2 | Carbocyclic purine nucleosides, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1987-04-29 | — | — | EP | disclosed |
| US-4613597-A | ANTICOAGULANTS, VASODILATORS, BRONCHODILATORS | GLAXO GROUP LIMITED (GB) | 1986-09-23 | — | — | US | disclosed |
| US-4282211-A | 1-Epi-2-deoxyfortimicin B and derivatives | ABBOTT LABORATORIES (US) | 1981-08-04 | — | — | US | disclosed |